Sterneck Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$277K Hold
301
0.12% 92
2025
Q4
$323K Sell
301
-3
-1% -$2.87K 0.15% 81
2025
Q3
$232K Hold
304
0.11% 90
2025
Q2
$237K Hold
304
0.12% 85
2025
Q1
$251K Sell
304
-12
-4% -$9.98K 0.14% 80
2024
Q4
$244K Buy
316
+4
+1% +$3.31K 0.13% 80
2024
Q3
$276K Hold
312
0.15% 70
2024
Q2
$282K Hold
312
0.16% 70
2024
Q1
$243K Buy
+312
New +$222K 0.15% 80

Other funds holding LLY

Sterneck Capital Management's LLY Position: Q1 2026 in Review

Sterneck Capital Management held its Eli Lilly (LLY) position steady in Q1 2026 at 301 shares worth $277K. The position accounts for 0.12% of the portfolio, ranked #92.

Sterneck Capital Management first reported a position in LLY in Q1 2024 and has held it in 9 quarters since. The position peaked at $323K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Sterneck Capital Management held 301 shares of Eli Lilly worth $277K as of Q1 2026.
  • Sterneck Capital Management left its Eli Lilly share count unchanged in Q1 2026.
  • Eli Lilly made up 0.12% of Sterneck Capital Management's portfolio in Q1 2026, its #92 holding.
  • Sterneck Capital Management first reported a position in Eli Lilly in Q1 2024 and has held it in 9 quarters since.
  • Sterneck Capital Management's Eli Lilly position peaked at $323K in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Sterneck Capital Management's 13F filing for Q1 2026, filed 17 Apr 2026.